2 results
Approved WMOCompleted
Efficacy and safety trial with S 44819 after recent ischemic cerebral Event
Approved WMORecruiting
The purpose of this study is to determine if the combination of relatlimab and nivolumab improves overall survival (OS) in all randomized participants and participants with PD-L1 CPS >= 1 with later-line metastatic colorectal cancer compared…